Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality training may boost stroke recovery

NCT ID NCT07113093

Disease control Sponsor: Ankara Yildirim Beyazıt University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 20, 2026 · Updated 2 times

Summary

This study tests whether using augmented reality (AR) or virtual reality (VR) during treadmill walking can improve balance and walking in people who have had a stroke. 66 participants will be split into three groups: one using VR, one using AR, and a control group doing home exercises. All will also receive standard physical therapy. The training lasts 45 minutes a day, five days a week, for three weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Augmented reality and virtual reality gait training
What this could lead to
If successful, this could offer a new, engaging way to improve balance and walking ability for stroke survivors.
What could go wrong
This is a small, early-stage trial with only 66 participants. The benefits may not be large or long-lasting, and results may not apply to all stroke patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Started

Aug 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ICD-10 diagnosis code of G.81 (Hemiplegia) * Age 18 years or older * Ability to walk with assistance or independently (Functional Ambulation Classification score of 2 or higher) Exclusion Criteria: * Incomplete completion of the assessment form * Refusal to participate in the study * Aphasia * Montreal Cognitive Assessment score below 10 * Presence of extra neurological or orthopedic problems unrelated to stroke * Recurrent stroke * MAS score of 3-4 (lower extremity) * Volunteer's desire to withdraw from the study * Inability to adapt to the technological devices used in the study (e.g., visual or hearing impairments) * Missing three consecutive treatment sessions * Botulinum toxin-A (BONT-A) injection to the lower extremity during the treatment process or within the last 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemiplegia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemiplegia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • Ankara Bilkent City Hospital

    Ankara, Çankaya, 06800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.